MedPath

NP-201

Generic Name
NP-201

IV Dosage Form of LCB01-0371 Phase I Study in Healthy Male Volunteers

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: LCB01-0371 400mg
First Posted Date
2016-08-30
Last Posted Date
2018-04-10
Lead Sponsor
LigaChem Biosciences, Inc.
Target Recruit Count
24
Registration Number
NCT02882789
Locations
🇰🇷

Bae KS, Seoul, Korea, Republic of

A Clinical Study, Randomized, Double-blind, Placebo-controlled, Single Dose Study

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2012-03-15
Last Posted Date
2014-11-17
Lead Sponsor
LigaChem Biosciences, Inc.
Target Recruit Count
70
Registration Number
NCT01554995
Locations
🇰🇷

Asan Medical Center, Seoul,, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath